Epclusa, Harvoni first alternatives on Express Scripts' new formulary

Express Scripts Holding Co. (NASDAQ:ESRX) introduced a new formulary Tuesday to help lower out-of-pocket costs and reduce dependence on

Read the full 194 word article

User Sign In